EDIT - Editas
Earnings Results

Editas ( $EDIT )

Recent earnings result

  1. Editas Medicine EPS misses by $0.81, misses on revenue

Events & Presentations

Q3 2019 Editas Medicine Inc. Earnings Conference Call

Supporting docs

  1. Listen to webcast

Top Stories (EDIT)

Events & Annual meetings

Title Date Webcast
Q3 2019 Editas Medicine Inc. Earnings Conference Call 11/12/19 8:00 AM EST edge.media-server.com webcast
Chardan 3rd Annual Genetic Medicines Conference 10/07/19 wsw.com webcast
Cell & Gene Meeting on the Mesa 10/04/19 9:45 AM PDT meetingonthemesa.com webcast
Morgan Stanley 17th Annual Global Healthcare Conference 09/09/19 2:15 PM EDT cc.talkpoint.com webcast
Citi 14th Annual Biotech Conference 09/05/19 8:00 AM EDT veracast.com webcast





Editas Medicine is building the leading genome editing company dedicated to treating patients with genetically defined diseases.


Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading